At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »Amazon shares rise when Goldman sets new high street price target
Text size Ina Fassbender / AFP via Getty Images Shares of Amazon.com were trading strongly higher on Monday in a pair of bullish analyst notes as Wall Street raises expectations ahead of the company’s earnings report to be released on July 30. The company is an obvious beneficiary of both …
Read More »Abbott, J&J results were fueled by June’s surprising surge in medical procedures, even as coronavirus cases rise
Abbott Laboratories and Johnson & Johnson separately reported recoveries from elective procedures earlier than expected in US hospitals in the second quarter, even as the nation struggles with an increasingly severe COVID-19 pandemic. Shares of Abbott ABT, + 2.95% closed at a year-to-date high of $ 99.25, the day after …
Read More »UK signs agreements with BioNTech, Pfizer and Valneva for COVID-19 vaccines
The UK government said on Monday it has secured early access to 90 million doses of vaccines from two potential COVID-19 vaccines developed by a partnership between Germany’s BioNTech and US drug maker Pfizer, as well as one by the group. French Valneva. The business ministry said it had signed …
Read More »Risks are mounting for US stocks. This is where investors should look, says BlackRock.
It is set to be a moderate start to a great earnings week. US stock futures were down at the start of a week, which will see a number of report results from big names, including Tesla TSLA, + 0.01%, Microsoft MSFT, -0.51% and United Airlines UAL, -1.65%. The race …
Read More »